ArticleMolecular medicine (Cambridge, Mass.)

The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.

Eli C Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.